264 related articles for article (PubMed ID: 12875772)
1. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus.
Diamant M; Lamb HJ; Groeneveld Y; Endert EL; Smit JW; Bax JJ; Romijn JA; de Roos A; Radder JK
J Am Coll Cardiol; 2003 Jul; 42(2):328-35. PubMed ID: 12875772
[TBL] [Abstract][Full Text] [Related]
2. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.
Rijzewijk LJ; van der Meer RW; Lamb HJ; de Jong HW; Lubberink M; Romijn JA; Bax JJ; de Roos A; Twisk JW; Heine RJ; Lammertsma AA; Smit JW; Diamant M
J Am Coll Cardiol; 2009 Oct; 54(16):1524-32. PubMed ID: 19815124
[TBL] [Abstract][Full Text] [Related]
3. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.
Rijzewijk LJ; van der Meer RW; Smit JW; Diamant M; Bax JJ; Hammer S; Romijn JA; de Roos A; Lamb HJ
J Am Coll Cardiol; 2008 Nov; 52(22):1793-9. PubMed ID: 19022158
[TBL] [Abstract][Full Text] [Related]
4. Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism.
Lamb HJ; Beyerbacht HP; van der Laarse A; Stoel BC; Doornbos J; van der Wall EE; de Roos A
Circulation; 1999 May; 99(17):2261-7. PubMed ID: 10226091
[TBL] [Abstract][Full Text] [Related]
5. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
Scheuermann-Freestone M; Madsen PL; Manners D; Blamire AM; Buckingham RE; Styles P; Radda GK; Neubauer S; Clarke K
Circulation; 2003 Jun; 107(24):3040-6. PubMed ID: 12810608
[TBL] [Abstract][Full Text] [Related]
6. Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I.
Metzler B; Schocke MF; Steinboeck P; Wolf C; Judmaier W; Lechleitner M; Lukas P; Pachinger O
J Cardiovasc Magn Reson; 2002; 4(4):493-502. PubMed ID: 12549236
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.
van der Meer RW; Rijzewijk LJ; de Jong HW; Lamb HJ; Lubberink M; Romijn JA; Bax JJ; de Roos A; Kamp O; Paulus WJ; Heine RJ; Lammertsma AA; Smit JW; Diamant M
Circulation; 2009 Apr; 119(15):2069-77. PubMed ID: 19349323
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular function and energy homeostasis in patients with type 1 diabetes with and without microvascular complications.
Perseghin G; Lattuada G; De Cobelli F; Esposito A; Canu T; Ragogna F; Maffi P; Scifo P; Secchi A; Del Maschio A; Luzi L
Int J Cardiol; 2012 Jan; 154(2):111-5. PubMed ID: 20926147
[TBL] [Abstract][Full Text] [Related]
9. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy.
Pluim BM; Lamb HJ; Kayser HW; Leujes F; Beyerbacht HP; Zwinderman AH; van der Laarse A; Vliegen HW; de Roos A; van der Wall EE
Circulation; 1998 Feb; 97(7):666-72. PubMed ID: 9495302
[TBL] [Abstract][Full Text] [Related]
10. Effects of weight loss on myocardial energetics and diastolic function in obesity.
Rider OJ; Francis JM; Tyler D; Byrne J; Clarke K; Neubauer S
Int J Cardiovasc Imaging; 2013 Jun; 29(5):1043-50. PubMed ID: 23269470
[TBL] [Abstract][Full Text] [Related]
11. Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls.
Ofstad AP; Urheim S; Dalen H; Orvik E; Birkeland KI; Gullestad L; W Fagerland M; Johansen OE; Aakhus S
J Diabetes; 2015 Nov; 7(6):779-90. PubMed ID: 25350248
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes.
Levelt E; Mahmod M; Piechnik SK; Ariga R; Francis JM; Rodgers CT; Clarke WT; Sabharwal N; Schneider JE; Karamitsos TD; Clarke K; Rider OJ; Neubauer S
Diabetes; 2016 Jan; 65(1):44-52. PubMed ID: 26438611
[TBL] [Abstract][Full Text] [Related]
13. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy.
Massie BM; Schaefer S; Garcia J; McKirnan MD; Schwartz GG; Wisneski JA; Weiner MW; White FC
Circulation; 1995 Mar; 91(6):1814-23. PubMed ID: 7882492
[TBL] [Abstract][Full Text] [Related]
14. Altered relative concentrations of high-energy phosphates in patients with uraemic cardiomyopathy measured by magnetic resonance spectroscopy.
Patel RK; Mark PB; Macnaught G; Stevens KK; McQuarrie EP; Steedman T; Gillis K; Dargie HJ; Jardine AG
Nephrol Dial Transplant; 2012 Jun; 27(6):2446-51. PubMed ID: 22241795
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study.
Perseghin G; Fiorina P; De Cobelli F; Scifo P; Esposito A; Canu T; Danna M; Gremizzi C; Secchi A; Luzi L; Del Maschio A
J Am Coll Cardiol; 2005 Sep; 46(6):1085-92. PubMed ID: 16168295
[TBL] [Abstract][Full Text] [Related]
16. Reduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction.
Maslov MY; Chacko VP; Hirsch GA; Akki A; Leppo MK; Steenbergen C; Weiss RG
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H332-7. PubMed ID: 20495142
[TBL] [Abstract][Full Text] [Related]
17. Reduced skeletal muscle phosphocreatine concentration in type 2 diabetic patients: a quantitative image-based phosphorus-31 MR spectroscopy study.
Ripley EM; Clarke GD; Hamidi V; Martinez RA; Settles FD; Solis C; Deng S; Abdul-Ghani M; Tripathy D; DeFronzo RA
Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E229-E239. PubMed ID: 29509433
[TBL] [Abstract][Full Text] [Related]
18. Aortic valve replacement in patients with aortic valve stenosis improves myocardial metabolism and diastolic function.
Beyerbacht HP; Lamb HJ; van Der Laarse A; Vliegen HW; Leujes F; Hazekamp MG; de Roos A; van Der Wall EE
Radiology; 2001 Jun; 219(3):637-43. PubMed ID: 11376247
[TBL] [Abstract][Full Text] [Related]
19. The relationship of cardiac diastolic dysfunction to concurrent hormonal and metabolic status in type I diabetes mellitus.
Ruddy TD; Shumak SL; Liu PP; Barnie A; Seawright SJ; McLaughlin PR; Zinman B
J Clin Endocrinol Metab; 1988 Jan; 66(1):113-8. PubMed ID: 3275682
[TBL] [Abstract][Full Text] [Related]
20. Enhanced sensitivity to hypoxia-induced diastolic dysfunction in pressure-overload left ventricular hypertrophy in the rat: role of high-energy phosphate depletion.
Wexler LF; Lorell BH; Momomura S; Weinberg EO; Ingwall JS; Apstein CS
Circ Res; 1988 Apr; 62(4):766-75. PubMed ID: 2964946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
